Document is current
Any future updates will be listed below
-
Authors
Liapis, Vasilios https://orcid.org/0000-0002-2354-3521
Wittwer, Nicole L.
Tieu, William
Gargett, Tessa
Brown, Michael P.
Staudacher, Alexander H.
-
Funding
Funding for this research was provided by:
Royal Adelaide Hospital Clinical Project Grant (12872)
AusHealth Pty Ltd
Ray and Shirl Norman Cancer Research Trust
Health Services Charitable Gifts Board, Adelaide
- License Information
-
More Information
Article History
Received: 5 February 2025
Accepted: 1 June 2025
First Online: 12 June 2025
Declarations
:
: The SAHMRI Animal Ethics Committee (Adelaide, Australia) approved all animal experiments, which were conducted following institutional ethical guidelines (Ethics approval numbers SAM172, SAM-21–112) which comply with the ARRIVE guidelines.The phase I trial was approved by the Central Adelaide Local Health Network Human Research Ethics Committee. The patient provided informed consent to participate in the phase I trial and consent for the data to be published.
: Michael P. Brown and Alexander H. Staudacher are co-inventors on APOMAB® related patents owned by AusHealth Pty Ltd and Telix Pharmaceuticals Ltd. No other authors have conflicts of interest to declare.
